BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1315 related articles for article (PubMed ID: 30518405)

  • 1. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
    Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
    J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway.
    Zhang JJ; Xu WR; Chen B; Wang YY; Yang N; Wang LJ; Zhang YL
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8321-8331. PubMed ID: 31646562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
    Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z
    Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA-SNHG7 acts as a target of miR-34a to increase GALNT7 level and regulate PI3K/Akt/mTOR pathway in colorectal cancer progression.
    Li Y; Zeng C; Hu J; Pan Y; Shan Y; Liu B; Jia L
    J Hematol Oncol; 2018 Jul; 11(1):89. PubMed ID: 29970122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased expression of ARHGAP15 promotes the development of colorectal cancer through PTEN/AKT/FOXO1 axis.
    Pan S; Deng Y; Fu J; Zhang Y; Zhang Z; Ru X; Qin X
    Cell Death Dis; 2018 Jun; 9(6):673. PubMed ID: 29867200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. γ-Glutamyl cyclotransferase contributes to tumor progression in high grade serous ovarian cancer by regulating epithelial-mesenchymal transition via activating PI3K/AKT/mTOR pathway.
    Li Y; Wu T; Wang Y; Yang L; Hu C; Chen L; Wu S
    Gynecol Oncol; 2018 Apr; 149(1):163-172. PubMed ID: 29429592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COPS5 and LASP1 synergistically interact to downregulate 14-3-3σ expression and promote colorectal cancer progression via activating PI3K/AKT pathway.
    Zhou R; Shao Z; Liu J; Zhan W; Gao Q; Pan Z; Wu L; Xu L; Ding Y; Zhao L
    Int J Cancer; 2018 May; 142(9):1853-1864. PubMed ID: 29226323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-cell RNA sequencing in double-hit lymphoma: IMPDH2 induces the progression of lymphoma by activating the PI3K/AKT/mTOR signaling pathway.
    Gao G; Xue Q; He J; Wu M; Jiang Y; Li Q; Zhang Y; Shi W
    Int Immunopharmacol; 2023 Dec; 125(Pt A):111125. PubMed ID: 37907047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [LncRNA SNHG11 promotes malignant progression of colorectal cancer cells through the PI3K/Akt/mTOR signaling pathway].
    Tao SN; Liu XC; Wang YY; Yang H
    Zhonghua Yi Xue Za Zhi; 2024 Mar; 104(10):758-765. PubMed ID: 38462356
    [No Abstract]   [Full Text] [Related]  

  • 10. GPR56 promotes proliferation of colorectal cancer cells and enhances metastasis via epithelial‑mesenchymal transition through PI3K/AKT signaling activation.
    Ji B; Feng Y; Sun Y; Ji D; Qian W; Zhang Z; Wang Q; Zhang Y; Zhang C; Sun Y
    Oncol Rep; 2018 Oct; 40(4):1885-1896. PubMed ID: 30066935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Actein antagonizes colorectal cancer through blocking PI3K/Akt pathways by downregulating IMPDH2.
    Yan L; Wang D; Liu X; Gu C; Gao S
    Anticancer Drugs; 2021 Sep; 32(8):864-874. PubMed ID: 33929996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor suppressive effect of scavenger receptor class A member 5 overexpression in colorectal cancer by regulating PI3K/AKT/mTOR pathway.
    Li Y; Peng F; Tan X; Wang J; Xu Y
    Genes Genomics; 2021 Oct; 43(10):1189-1198. PubMed ID: 34417976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deoxyshikonin isolated from
    Zhu Y; Zhong Y; Long X; Zhu Z; Zhou Y; Ye H; Zeng X; Zheng X
    Pharm Biol; 2019 Dec; 57(1):412-423. PubMed ID: 31230505
    [No Abstract]   [Full Text] [Related]  

  • 14. LncRNA ST3Gal6-AS1/ST3Gal6 axis mediates colorectal cancer progression by regulating α-2,3 sialylation via PI3K/Akt signaling.
    Hu J; Shan Y; Ma J; Pan Y; Zhou H; Jiang L; Jia L
    Int J Cancer; 2019 Jul; 145(2):450-460. PubMed ID: 30613961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FAT4 regulates the EMT and autophagy in colorectal cancer cells in part via the PI3K-AKT signaling axis.
    Wei R; Xiao Y; Song Y; Yuan H; Luo J; Xu W
    J Exp Clin Cancer Res; 2019 Mar; 38(1):112. PubMed ID: 30832706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Glut1 gene silencing on proliferation, differentiation, and apoptosis of colorectal cancer cells by targeting the TGF-β/PI3K-AKT-mTOR signaling pathway.
    Wu XL; Wang LK; Yang DD; Qu M; Yang YJ; Guo F; Han L; Xue J
    J Cell Biochem; 2018 Feb; 119(2):2356-2367. PubMed ID: 28884839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt/β-catenin signalling activates IMPDH2-mediated purine metabolism to facilitate oxaliplatin resistance by inhibiting caspase-dependent apoptosis in colorectal cancer.
    Huang Y; Chan S; Chen S; Liu X; Li M; Zheng L; Dong Z; Yang Z; Liu Z; Zhou D; Zhang X; Zhang B
    J Transl Med; 2024 Feb; 22(1):133. PubMed ID: 38310229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DCLK1 promotes epithelial-mesenchymal transition via the PI3K/Akt/NF-κB pathway in colorectal cancer.
    Liu W; Wang S; Sun Q; Yang Z; Liu M; Tang H
    Int J Cancer; 2018 May; 142(10):2068-2079. PubMed ID: 29277893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyrroline-5-Carboxylate Reductase-2 Promotes Colorectal Cancer Progression via Activating PI3K/AKT/mTOR Pathway.
    Yin F; Huang X; Xuan Y
    Dis Markers; 2021; 2021():9950663. PubMed ID: 34512817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LINC01296/miR-26a/GALNT3 axis contributes to colorectal cancer progression by regulating O-glycosylated MUC1 via PI3K/AKT pathway.
    Liu B; Pan S; Xiao Y; Liu Q; Xu J; Jia L
    J Exp Clin Cancer Res; 2018 Dec; 37(1):316. PubMed ID: 30547804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 66.